[Nimodipine in ischemic cerebropathy].
Fifty patients of either sex with acute and chronic cerebrovascular disorders were submitted to an observation protocol and treated with oral nimodipine (tablets or drops) at a daily dosage of 90 mg for 1 to 3 months. Nimodipine proved useful both from the therapeutic point of view and for its easy handling in acute pathology (TIA, RIND, minor stroke, complete stroke) as well as chronic cerebral ischemia. The drug was well tolerated both locally and systemically; in patients with concomitant arterial hypertension, nimodipine reduced blood pressure with a tendency towards stabilization at near-normal levels.
Di Lascio
G
G
Divisione di Medicina, Ospedale Civile Polispecializzato di Anzio.
Salvini
S
S
D000368:Aged; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009553:Nimodipine / Q000627:therapeutic use*
D009553:Nimodipine
Nimodipina nella cerebropatia ischemica.